These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 996046)

  • 21. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 22. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase of brain levels of tryptophan induced by inhibition of dopamine beta-hydroxylase (EC 1.14.2.1).
    Johnson GA; Kim EG
    J Neurochem; 1973 Jun; 20(6):1761-4. PubMed ID: 4719318
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term suppression of the development of complementary memory storage sites in mice: functional interdependence of acetylcholine and dopamine.
    Flexner JB; Church AC; Flexner LB
    Pharmacol Biochem Behav; 1992 Oct; 43(2):617-9. PubMed ID: 1438499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect with time of a norepinephrine synthesis inhibitor (U-14,624) on hypothalamic catecholamine and plasma gonadotrophin concentrations in the ovariectomized rat.
    Kohn SR; Morgan WW; Carrillo AJ
    J Reprod Fertil; 1982 Sep; 66(1):185-8. PubMed ID: 6811733
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term suppression in mice of the development of complementary memory storage sites: effect of a muscarinic antagonist.
    Flexner LB; Flexner JB; Church AC
    Pharmacol Biochem Behav; 1991 Jul; 39(3):689-94. PubMed ID: 1784597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase.
    Lotti VJ; Torchiana ML; Stone CA
    Eur J Pharmacol; 1977 Aug; 44(4):387-90. PubMed ID: 19268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I
    Endocrinologie; 1978; 16(4):263-8. PubMed ID: 569899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A; Jenner P; Marsden CD
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A; Elliott PN; Jenner P
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract]   [Full Text] [Related]  

  • 31. Puromycin's suppression of memory in mice as affected by caffeine.
    Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1975; 3(1):13-7. PubMed ID: 1168926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal rhythm in the central dopamine turnover in the rat.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):257-61. PubMed ID: 567283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebral saline: effect on memory of trained mice treated with puromycin.
    Flexner LB; Flexner JB
    Science; 1968 Jan; 159(3812):330-1. PubMed ID: 5688688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of variations in adrenocortical function on dopamine beta-hydroxylase and norepinephrine in the brain of the rat.
    Shen JT; Ganong WF
    J Pharmacol Exp Ther; 1976 Dec; 199(3):639-48. PubMed ID: 994021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory in mice analyzed with antibiotics. Antibiotics are useful to study stages of memory and to indicate molecular events which sustain memory.
    Flexner LB; Flexner JB; Roberts RB
    Science; 1967 Mar; 155(3768):1377-83. PubMed ID: 6018502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.